Best Hospitals for Vasculitis treatment in Israel 2026

Top vasculitis specialists in Israel include Prof. Dan Kaspy and Prof. Ori Elkayam at Sourasky Medical Center. Prof. Merav Lidar and Prof. Pnina Langevitz lead advanced immunology programs at Sheba Medical Center. These experts utilize biological therapies and specialized diagnostics for complex autoimmune cases.

• Prof. Dan Kaspy: Works at Sourasky Medical Center specializing in complex rheumatology.
• Prof. Merav Lidar: Heads the Center for Autoimmune Diseases at Sheba Medical Center.
• Prof. Eldad Ben-Chetrit: Specializes in autoinflammatory diseases at Hadassah Medical Center.
• Clinical expertise: Israeli specialists often hold leadership roles in the Israeli Association of Rheumatology.

Bookimed Expert Insight: Israeli rheumatology departments show a distinct pattern of specialization across different hospitals. While Sourasky Medical Center serves over 400,000 patients annually and excels in research trials, Sheba Medical Center is the primary hub for rare refractory cases. For patients requiring high-tech biological infusions like rituximab, university-affiliated public hospitals often provide more established clinical protocols than smaller private clinics.

Patient Consensus: Patients note that while treatment quality is exceptional, navigating hospital bureaucracy is challenging without professional logistics support. Many emphasize the importance of choosing major centers like Sheba or Rabin for comprehensive biopsy and steroid protocols.

Israeli clinics provide advanced vasculitis treatments including CAR-T cell therapy, biologic protocols, and extracorporeal hemocorrection. Specialists at JCI-accredited centers like Sourasky Medical Center (Ichilov) utilize rituximab, JAK inhibitors, and tocilizumab. These therapies target specific immune pathways to manage systemic inflammation and prevent organ damage effectively.

• Biologic therapy: Targeted drugs like rituximab and tocilizumab block specific inflammatory proteins.
• CAR-T therapy: Innovative T-cell engineering at Sheba Medical Center treats resistant ANCA-associated cases.
• Plasma exchange: Plasmapheresis removes harmful autoantibodies from the blood during acute flares.
• Precision diagnostics: Multimodal imaging with PET-CT and MRI tracks large-vessel vascular changes.

Bookimed Expert Insight: Israeli rheumatology departments often provide faster access to experimental biologic combinations. Data shows centers like Sourasky Medical Center (Ichilov) integrate research directly into clinical care. Dr. Dan Kaspy leads the Rheumatology Department there with extensive international expertise. This connection to research allows patients to access JAK inhibitors and personalized dosing protocols earlier.

Patient Consensus: Patients appreciate that Israeli hospitals use genetic profiling to tailor biologic treatments. They note that the multidisciplinary teams react quickly to adjust dosages based on real-time monitoring.

Top Israeli hospitals for vasculitis include Sheba Medical Center and Sourasky Medical Center. These facilities utilize multidisciplinary teams and advanced biological treatments. Clinics often hold Joint Commission International (JCI) accreditation. Specialized centers like Hadassah and Rambam provide research-driven care for complex autoimmune conditions.

• Specialized expertise: Dr. Dan Kaspy at Sourasky focuses on complex rheumatology and immunology.
• Advanced diagnostics: Facilities use digital imaging and AI to identify specific vasculitis types.
• Clinical research: University hospitals like Hadassah integrate new discoveries into patient treatment plans.
• Treatment range: Options include biological therapies and experimental protocols for refractory cases.

Bookimed Expert Insight: While Israel has 26 clinics in our network, Sourasky Medical Center stands out for its high volume. It serves over 1,800,000 patients annually and employs 2,200 doctors. This massive scale allows for extreme specialization. Dr. Dan Kaspy, for example, is a founding member of Israel’s rheumatology programs. For rare conditions like vasculitis, choosing a high-volume academic center ensures access to such foundational expertise.

Patient Consensus: Patients note that research-driven units at centers like Hadassah often provide faster access to biologics. Many suggest using private insurance to bypass long public waitlists for specialist consultations.

International patients usually stay 2 to 4 weeks for advanced vasculitis treatment in Israel. This window covers diagnostics, treatment initiation, and acute monitoring. Cases involving renal or pulmonary complications often require 3 to 4 weeks. Oral-only regimens may allow for shorter stays of 7 to 10 days.

• Diagnostic phase: Comprehensive workups typically require 5 to 10 days in Tel Aviv clinics.
• Intensive induction: IV immunosuppression protocols generally last 10 to 21 days for initial infusions.
• Inpatient care: Severe systemic cases often involve 9 to 16 days of specialized hospitalization.
• Advanced therapies: Cellular treatments like CAR-T therapy may extend total stays to 10 weeks.

Bookimed Expert Insight: Coordination between Israeli specialists and home doctors is the most effective way to reduce stay duration. At Sourasky Medical Center, experts like Dr. Dan Kaspy oversee complex cases that often involve multiple departments. Patients who arrange for remote follow-ups after 10 to 14 days of stabilization can safely transition to maintenance therapy at home. Choosing a facility with built-in telemedicine capabilities ensures ongoing care without requiring monthly return flights to Israel.

Patient Consensus: Patients note it's important to build in a 5-day buffer for unexpected lab repeats or imaging. They emphasize that while the initial stay is intense, transition to maintenance therapy usually happens smoothly after the first month.